Benzinga's Top Downgrades

Analysts at Barclays downgraded

from Equal-weight to Underweight. The price target for AthenaHealth has been lowered from $140 to $110. AthenaHealth shares closed at $162.98 on Monday. Analysts at Brean Capital downgraded

from Hold to Sell. The price target for Osiris Therapeutics is set to $8. Osiris Therapeutics shares closed at $13.98 on Monday. Wedbush downgraded

from Outperform to Neutral. The price target for Polaris Industries has been lowered from $156 to $117. Polaris Industries shares closed at $105.49 on Monday. RBC Capital downgraded

from Outperform to Sector Perform. The price target for Urban Outfitters has been lowered from $32 to $23. Urban Outfitters shares closed at $22.67 on Monday. Analysts at Sterne Agee CRT downgraded

from Buy to Neutral. The price target for Five Below has been lowered to $30. Five Below shares closed at $28.49 on Monday. BMO Capital downgraded

from Outperform to Market Perform. The price target for Kindred Biosciences has been lowered from $14 to $5. Kindred Biosciences shares closed at $4.73 on Monday. Analysts at Oppenheimer downgraded

from Outperform to Perform. Hess shares closed at $61.84 on Monday. Atlantic Equities downgraded

from Neutral to Underweight. The price target for W W Grainger has been lowered from $220 to $183. W W Grainger shares closed at $198.28 on Monday. Analysts at KeyBanc downgraded

from Overweight to Sector Weight. Airgas shares closed at $106.18 on Monday. Analysts at Goldman Sachs downgraded

from Buy to Neutral. The price target for Clovis Oncology has been lowered from $123 to $23. Clovis Oncology shares closed at $30.24 on Monday.